title: Drug therapy: telaprevir.
authors: Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
authors: Michael D
authors: MD
authors: Leise
authors: W Ray
authors: WR
authors: Kim
authors: Katherine M
authors: KM
authors: Canterbury
authors: John J
authors: JJ
authors: Poterucha
mesh_terms: D001707:Biopsy, Needle; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D005500:Follow-Up Studies; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D008103:Liver Cirrhosis / Q000473:pathology* / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000008:administration & dosage* / Q000009:adverse effects; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D009842:Oligopeptides; D011480:Protease Inhibitors; C486464:telaprevir